Stock vs Stock Comparison

Axon Enterprise, Inc. vs Arcosa, Inc.

ACA wins the Tale of the Tape 5–4.

AXON$481.48
ACA

🏆 Tale of the Tape

45
AXONACA
4.5%Profitability (Net Margin)7.2%
181.7xValuation (P/E)28.3x
1.6%Efficiency (ROIC)6.2%
5/9Health (Piotroski F)8/9
5.5Safety (Altman Z)
33.5%Growth (Rev YoY)12.2%
-0.66Risk (Sharpe 1Y)
1.16xBalance Sheet (D/E)0.89x
0.26%FCF Yield

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricAXONACA
Market Cap$36.2B$5.9B
P/E Ratio181.7x28.3x
Forward P/E42.4x22.4x
P/B10.23x2.23x
Dividend Yield0.17%
Beta1.440.96

Quantitative Metrics

MetricAXONACA
DCF Fair Value$6.47$99.96
DCF Upside-98.2%
Piotroski F5/98/9
Altman Z5.46
Beneish M-2.21-2.48
FCF Yield0.26%
Net Debt/EBITDA2.7x2.3x
ROIC1.6%6.2%
WACC14.0%
ROIC – WACC-12.4pp
Gross Margin59.7%22.4%
Net Margin4.5%7.2%
Rev Growth YoY33.5%12.2%
Sharpe (1Y)-0.66
Max Drawdown 3Y-60.3%
FCF Payout Ratio6%

AXON Price

Loading chart...

ACA Price

Loading chart...

ETF Exposure

AXON found in:

XAR2.38%
VOT0.72%
XLI0.58%
VIS0.43%
VO0.31%
QQQ0.25%
RSP0.17%
SCHG0.16%
IWF0.12%
SPLG0.10%
VONG0.10%
VUG0.10%
IVV0.08%
SCHX0.07%
ITOT0.07%
SCHB0.06%
ESGV0.06%
SPYG0.06%
VOO0.05%
VONE0.05%
SPY0.05%
URTH0.05%
SPTM0.04%
VTI0.04%
ACWI0.04%
SPYV0.04%
ONEO0.01%
QUS0.00%

ACA found in:

SLYG0.45%
SPSM0.35%
SLYV0.25%
VTWO0.18%
VFMO0.15%
VBR0.14%
VGK0.12%
VYMI0.10%
VIS0.09%
SPDW0.08%
VB0.08%
VXF0.08%
VEA0.06%
VSGX0.06%
CWI0.05%
VEU0.05%
VXUS0.04%
SPTM0.01%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

AXON vs ACA: Head-to-Head Analysis

Axon Enterprise, Inc. (AXON) and Arcosa, Inc. (ACA) represent two companies in the Industrials sector. In our quantitative Tale of the Tape scoring, ACA leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, AXON generates a return on invested capital (ROIC) of 1.6% compared to ACA's 6.2%. This suggests ACA is more effective at deploying capital to generate shareholder returns.

AXON appears in 28 ETFs tracked by SecuritiesDB, while ACA appears in 18 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, AXON or ACA?

Our quantitative analysis compares AXON and ACA across nine fundamental dimensions. ACA wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are AXON and ACA correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.